Viral Infections and Cutaneous Drug-Related Eruptions.

dc.contributor.authorAnci, Eleonora
dc.contributor.authorBraun, Camille
dc.contributor.authorMarinosci, Annalisa
dc.contributor.authorRodieux, Frédérique
dc.contributor.authorMidun, Elise
dc.contributor.authorTorres, Maria-Jose
dc.contributor.authorCaubet, Jean-Christoph
dc.date.accessioned2025-01-07T15:01:52Z
dc.date.available2025-01-07T15:01:52Z
dc.date.issued2021-03-10
dc.description.abstractIn the general population, up to 10% of children treated by antibiotics have cutaneous adverse drug reaction, but allergy is confirmed in less than 20% of patients. Most of the non-allergic reactions are probably due to virus, such as enterovirus acute infection or Ebstein-Barr Virus (EBV) acute infection or reactivation. Especially in children, viruses have the propensity to induce skin lesions (maculopapular rash, urticaria) due to their skin infiltration or immunologic response. In drug-related skin eruptions, a virus can participate by activating an immune predisposition. The culprit antibiotic is then the trigger for reacting. Even in severe drug-induced reactions, such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, viruses take part in immune phenomena, especially herpes viruses. Understanding the mechanisms of both virus- and drug-induced skin reaction is important to develop our clinical reflection and give an adaptive care to the patient. Our aim is to review current knowledge on the different aspects and potential roles of viruses in the different type of drug hypersensitivity reactions (DHR). Although major advances have been made those past year, further studies are needed for a better understanding of the link between viruses and DHR, to improve management of those patients.
dc.identifier.doi10.3389/fphar.2020.586407
dc.identifier.issn1663-9812
dc.identifier.pmcPMC7988096
dc.identifier.pmid33776753
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7988096/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fphar.2020.586407/pdf
dc.identifier.urihttps://hdl.handle.net/10668/26813
dc.journal.titleFrontiers in pharmacology
dc.journal.titleabbreviationFront Pharmacol
dc.language.isoen
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.page.number586407
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectallergy
dc.subjectdrug
dc.subjecthypersensitivity
dc.subjectmechanism
dc.subjectvirus
dc.titleViral Infections and Cutaneous Drug-Related Eruptions.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC7988096.pdf
Size:
941.19 KB
Format:
Adobe Portable Document Format